Pfizer, Inc. (NYSE:PFE)

CAPS Rating: 4 out of 5

A research-based pharmaceutical company, Pfizer discovers, develops, manufactures, and markets prescription medicines such as Lipitor, Celebrex, and Viagra.


Player Avatar mcornice1 (27.80) Submitted: 12/2/2010 3:00:39 PM : Underperform Start Price: $14.17 PFE Score: -51.83

Not a very well run company. A science company being run by a bunch of businessmen does not produce good results. Sure the dividend and their cash is nice, but I have no confidence that Pfizer can actually achieve something scientifically viable on their own. They'll keep buying small companies and downsizing, but at some point, that model cannot sustain itself. Novartis is a much better bet in big pharma.

Featured Broker Partners